<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
        </div>
        <div class="card-body">
                <p>Acute promyelocytic leukemia (APL) is associated with chromosomal translocations involving retinoic acid receptor alpha (RAR alpha) and its fusion partners including promyelocytic leukemia (PML) and promyelocytic leukemia zinc finger (PLZF). Using oligonucleotide arrays, we examined changes in global gene expression mediated by the ectopic expression of either PML/RAR alpha (retinoid-sensitive) or PLZF/RAR alpha (retinoid-resistant) in U937 cells. Of more than 5000 genes analyzed, 16 genes were commonly up-regulated, and 57 genes were down-regulated by both fusion proteins suggesting their role in the APL phenotype. In our APL model, for example, TNFAIP2, TNFR2, ELF4, RAR gamma, and HoxA1 were down-regulated by both fusion proteins in the absence of retinoic acid (RA). RA strongly up-regulated these genes in PML/RAR alpha, but not in PLZF/RAR alpha expressing U937 cells. Expression studies in NB4, retinoid-resistant NB4-R2, normal human CD34+ cells, and APL patient samples strongly suggest their role in the regulation of granulocytic differentiation. Furthermore, combined treatment with tumor necrosis factor alpha (TNF alpha) and RA synergistically enhanced granulocytic differentiation in NB4 cells but not in NB4-R2 cells. Our data indicate that APL pathogenesis and retinoid-induced granulocytic differentiation of APL cells involve genes in the cell death pathway, and that cooperation between the RA and TNFalpha signaling pathways exists. Targeting both the retinoid-dependent differentiation and the cell death pathways may improve leukemic therapy, especially in retinoid-resistant acute myeloid leukemia.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M19270">M19270</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:5916">ncbigene:5916</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:952">ncbigene:952</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8870">ncbigene:8870</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4046">ncbigene:4046</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6518">ncbigene:6518</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1050">ncbigene:1050</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9516">ncbigene:9516</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:653361">ncbigene:653361</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7127">ncbigene:7127</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1053">ncbigene:1053</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3489">ncbigene:3489</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5660">ncbigene:5660</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5292">ncbigene:5292</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7133">ncbigene:7133</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23526">ncbigene:23526</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5585">ncbigene:5585</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:241">ncbigene:241</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7150">ncbigene:7150</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3659">ncbigene:3659</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6688">ncbigene:6688</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3727">ncbigene:3727</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10397">ncbigene:10397</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10507">ncbigene:10507</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7378">ncbigene:7378</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2268">ncbigene:2268</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6503">ncbigene:6503</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2000">ncbigene:2000</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3198">ncbigene:3198</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:638">ncbigene:638</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3417">ncbigene:3417</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M19270&#39;, name=&#39;PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION&#39;), definition=&#39;Acute promyelocytic leukemia (APL) is associated with chromosomal translocations involving retinoic acid receptor alpha (RAR alpha) and its fusion partners including promyelocytic leukemia (PML) and promyelocytic leukemia zinc finger (PLZF). Using oligonucleotide arrays, we examined changes in global gene expression mediated by the ectopic expression of either PML/RAR alpha (retinoid-sensitive) or PLZF/RAR alpha (retinoid-resistant) in U937 cells. Of more than 5000 genes analyzed, 16 genes were commonly up-regulated, and 57 genes were down-regulated by both fusion proteins suggesting their role in the APL phenotype. In our APL model, for example, TNFAIP2, TNFR2, ELF4, RAR gamma, and HoxA1 were down-regulated by both fusion proteins in the absence of retinoic acid (RA). RA strongly up-regulated these genes in PML/RAR alpha, but not in PLZF/RAR alpha expressing U937 cells. Expression studies in NB4, retinoid-resistant NB4-R2, normal human CD34+ cells, and APL patient samples strongly suggest their role in the regulation of granulocytic differentiation. Furthermore, combined treatment with tumor necrosis factor alpha (TNF alpha) and RA synergistically enhanced granulocytic differentiation in NB4 cells but not in NB4-R2 cells. Our data indicate that APL pathogenesis and retinoid-induced granulocytic differentiation of APL cells involve genes in the cell death pathway, and that cooperation between the RA and TNFalpha signaling pathways exists. Targeting both the retinoid-dependent differentiation and the cell death pathways may improve leukemic therapy, especially in retinoid-resistant acute myeloid leukemia.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;12893766&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5916&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;952&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8870&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4046&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6518&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1050&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9516&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;653361&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7127&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1053&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3489&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5660&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5292&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7133&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23526&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5585&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;241&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7150&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3659&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6688&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3727&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10397&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10507&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7378&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2268&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6503&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2000&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3198&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;638&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3417&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 2: U937PR9 (PML/RAR alpha)&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>